Trials / Recruiting
RecruitingNCT07302607
Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 221 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Although impressive progress has been made with this new therapeutic strategy, only a proportion of patients achieve a complete and sustained response. Studies have already identified predictive factors of treatment response that are now widely recognized. In this study, the investigators aim to identify other response factors not yet evaluated in the literature.
Conditions
Timeline
- Start date
- 2024-12-11
- Primary completion
- 2026-01-01
- Completion
- 2026-01-01
- First posted
- 2025-12-24
- Last updated
- 2025-12-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07302607. Inclusion in this directory is not an endorsement.